Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:53 AM
Ignite Modification Date:
2025-12-25 @ 12:53 AM
NCT ID:
NCT07115667
Eligibility Criteria:
Inclusion Criteria:
* ≥18 years old
* Histologically confirmed SBP with \<10% clonal plasma cells in marrow
* ECOG ≤ 2
* No prior anti-myeloma therapy. Previous local radiotherapy for SBP is not an exclusion criterion.
* Meets laboratory and imaging criteria
Exclusion Criteria:
1. Patients who have previously received anti-plasma cell therapy, including melphalan, cyclophosphamide, proteasome inhibitors, immunomodulatory drugs, monoclonal antibodies, bispecific antibodies, or chimeric antigen receptor T-cell (CAR-T) therapy.
2. Any condition that, in the opinion of the investigator, would make the patient unsuitable for participation in this study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
78 Years
Study:
NCT07115667
Study Brief:
Protocol Section:
NCT07115667